Anna Rosell Novel Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory. Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Email Anna Rosell Novel Email Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.
As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).
Projects Malalties Neurovasculars (GRC) IP: Joan Montaner Villalonga Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 48000 Reference: 2014 SGR 686 Duration: 01/01/2014 - 31/12/2016 Estudio de la angiogénesis en pacientes en rehabilitación después del ictus: búsqueda de marcadores de recuperación funcional e identificación de nuevas dianas terapéuticas IP: Anna Rosell Novel Collaborators: Susana Rodriguez Gonzalez, María Inmaculada Bori de Fortuny Funding agency: Instituto de Salud Carlos III Funding: 103455 Reference: PI13/01094 Duration: 01/01/2014 - 30/04/2017 La interacció de progenitors cel·lulars en el cervell depèn de les metal·loproteïnases de matriu IP: Joan Montaner Villalonga Collaborators: Anna Rosell Novel Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 5159 Reference: 2012 BE1 00709 Duration: 01/07/2013 - 31/08/2013 Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach IP: - Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Rafael Simó Canonge, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero Funding agency: Instituto de Salud Carlos III Funding: 825000 Reference: PIE13/00027 Duration: 01/01/2014 - 30/06/2018 Pagination First page « Previous page ‹ … Page 5 Page 6 Current page 7 Page 8 Page 9 … Next page › Last page »
